Advanced search
1 file | 85.62 KB

Eculizumab (ECU) inhibits thrombotic microangiopathy (TMA) and improves renal function in pediatric patients (Pts) with atypical hemolytic uremic syndrome (aHUS)

(2013) BLOOD. 122(21).
Author
Organization

Downloads

  • ECu - ASH C10-003 FINAL Submitted 8 8 13.docx
    • full text
    • |
    • open access
    • |
    • Word
    • |
    • 85.62 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Greenbaum, Larry A, Marc Fila, Gianluigi Ardissino, Samhar I Al-Akash, Jonathan Evans, Paul Henning, Kenneth V Lieberman, et al. 2013. “Eculizumab (ECU) Inhibits Thrombotic Microangiopathy (TMA) and Improves Renal Function in Pediatric Patients (Pts) with Atypical Hemolytic Uremic Syndrome (aHUS).” In Blood. Vol. 122.
APA
Greenbaum, L. A., Fila, M., Ardissino, G., Al-Akash, S. I., Evans, J., Henning, P., Lieberman, K. V., et al. (2013). Eculizumab (ECU) inhibits thrombotic microangiopathy (TMA) and improves renal function in pediatric patients (Pts) with atypical hemolytic uremic syndrome (aHUS). BLOOD (Vol. 122). Presented at the 55th Annual meeting and exposition of the American Society of Hematology (ASH 2013).
Vancouver
1.
Greenbaum LA, Fila M, Ardissino G, Al-Akash SI, Evans J, Henning P, et al. Eculizumab (ECU) inhibits thrombotic microangiopathy (TMA) and improves renal function in pediatric patients (Pts) with atypical hemolytic uremic syndrome (aHUS). BLOOD. 2013.
MLA
Greenbaum, Larry A, Marc Fila, Gianluigi Ardissino, et al. “Eculizumab (ECU) Inhibits Thrombotic Microangiopathy (TMA) and Improves Renal Function in Pediatric Patients (Pts) with Atypical Hemolytic Uremic Syndrome (aHUS).” Blood. Vol. 122. 2013. Print.
@inproceedings{4110165,
  articleno    = {abstract 2191},
  author       = {Greenbaum, Larry A and Fila, Marc and Ardissino, Gianluigi and Al-Akash, Samhar I and Evans, Jonathan and Henning, Paul and Lieberman, Kenneth V and Maringhini, Silvio and Pape, Lars and Rees, Lesley and Van De Kar, Nicole and Vande Walle, Johan and Ogawa, Masayo and Bedrosian, Camille L and Licht, Christoph},
  booktitle    = {BLOOD},
  issn         = {0006-4971},
  language     = {eng},
  location     = {New Orleans, LA, USA},
  number       = {21},
  title        = {Eculizumab (ECU) inhibits thrombotic microangiopathy (TMA) and improves renal function in pediatric patients (Pts) with atypical hemolytic uremic syndrome (aHUS)},
  volume       = {122},
  year         = {2013},
}

Web of Science
Times cited: